TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18773532

Group type: EXPERIMENTAL
Intervention: Cleavage stage embryos transferred on day two or three
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single embryo transfer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three embryos transferred
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four embryos transferred
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More embryos than recommended
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fewer embryos transferred
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counseling regarding risks of multifetal gestation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Public funding strategy for IVF-ET
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guidelines for cycle cancellation
Number of subjects: 0
Study: 11137632

Group type: EXPERIMENTAL
Intervention: OptiBond Solo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1
Number of subjects: 33
Study: 9145453

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (A, C, and E)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 209

Group type: COMPARATOR
Intervention: No treatment (untreated controls)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg/day)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Lower doses of antioxidant vitamins
Number of subjects: 209
Study: 7969600

Group type: EXPERIMENTAL
Intervention: Touching of own genitals
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Playing doctor
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Adult-like sexual behaviour
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Family nudity
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Parental education level
Number of subjects: 362
Study: 3679735

Group type: EXPERIMENTAL
Intervention: Early physiotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Delayed physiotherapy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Conservative procedure
Number of subjects: 68
Study: 31895774

Group type: COMPARATOR
Intervention: MAC (conventional Macintosh laryngoscope without additional intubation aids)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: GEB (conventional Macintosh laryngoscope with gum‐elastic bougie)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: FTB (flexible tip bougie)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: GEB
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: FTB
Number of subjects: 39

Group type: COMPARATOR
Intervention: MAC
Number of subjects: 39
Study: 31138171

Group type: EXPERIMENTAL
Intervention: Peer-Led physical Activity intervention (PLAN-A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Self-report psychosocial questionnaire
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Economic evaluation measures
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mixed-methods process evaluation
Number of subjects: 20
Study: 28410972

Group type: EXPERIMENTAL
Intervention: Authentic Connections Groups (n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition (n = 19)
Number of subjects: 40
Study: 26176848

Group type: EXPERIMENTAL
Intervention: EC-MPS
Number of subjects: 101

Group type: COMPARATOR
Intervention: MMF
Number of subjects: 101
Study: 23278851

Group type: EXPERIMENTAL
Intervention: Ciclopirox lacquer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle lacquer
Number of subjects: 40
Study: 21526411

Group type: EXPERIMENTAL
Intervention: Pharmacy First Minor Ailments scheme
Number of subjects: 0
Study: 18059393

Group type: EXPERIMENTAL
Intervention: Total antibiotic use
Number of subjects: 1348

Group type: EXPERIMENTAL
Intervention: Antibiotic use by site
Number of subjects: 1348

Group type: EXPERIMENTAL
Intervention: Frequency of antibiotic use
Number of subjects: 1348

Group type: EXPERIMENTAL
Intervention: Age at first antibiotic use
Number of subjects: 1348
Study: 17044452

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (ID group) - 10 microg of recombinant hepatitis B vaccine (Engerix B) intradermally every 2 weeks for a total of 7 doses.
Number of subjects: 51

Group type: COMPARATOR
Intervention: Intramuscular vaccination (IM group) - 40 microg intramuscularly at 0, 1, 2, and 6 months.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (ID group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Intramuscular vaccination (IM group)
Number of subjects: 51
Study: 12830437

Group type: EXPERIMENTAL
Intervention: Daily Hemodialysis (n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nocturnal Hemodialysis (n = 12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional Thrice-Weekly Hemodialysis (Control)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Quotidian HD patients using catheters
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Patients with AV fistulae
Number of subjects: 23

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 23
Study: 10952796

Group type: EXPERIMENTAL
Intervention: MCT + LCT
Number of subjects: 36

Group type: COMPARATOR
Intervention: LCT alone
Number of subjects: 36
Study: 9417514

Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (historical control without specific prophylaxis)
Number of subjects: 50
Study: 1583246

Group type: EXPERIMENTAL
Intervention: ICI 204,219 (40 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 28926197

Group type: EXPERIMENTAL
Intervention: Cataract surgery followed by pars plana vitrectomy (CAT group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy followed by cataract surgery (VIT group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification‐vitrectomy (COMBI group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cataract surgery (CAT group)
Number of subjects: 62
Study: 26842261

Group type: EXPERIMENTAL
Intervention: Dynamic exposure to alcohol advertising during sports events
Number of subjects: 108

Group type: COMPARATOR
Intervention: No advertising exposure
Number of subjects: 108
Study: 26608342

Group type: EXPERIMENTAL
Intervention: Non-alcohol antimicrobial mouth rinse containing cetylpyridinium chloride and oral health education
Number of subjects: 468

Group type: COMPARATOR
Intervention: Control group received a package of toothbrush and paste, plus oral hygiene education
Number of subjects: 468
Study: 23885612

Group type: EXPERIMENTAL
Intervention: Electroacupuncture with penetration needling method (group A)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Jiaji electroacupuncture (group B)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Jing fukang granule (group C)
Number of subjects: 160
Study: 20568432

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (needles at Zusanli (ST 36), Zhongwan (CV 12), Weishu (BL 21), Neiguan (PC 6), once a day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Medication treatment (20 mg Omeprazole, once a day)
Number of subjects: 61
Study: 18489927

Group type: COMPARATOR
Intervention: Low-fat diet (n = 50)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Mediterranean-style diet (n = 51)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined dietary intervention (n = 101)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual-care controls (n = 101)
Number of subjects: 101
Study: 16519864

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol and Atropine
Number of subjects: 0

Group type: COMPARATOR
Intervention: PDM methodology
Number of subjects: 0
Study: 12930517

Group type: EXPERIMENTAL
Intervention: L-E-GTF
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Soluble E-GTF
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both groups (L-E-GTF and Soluble E-GTF)
Number of subjects: 12
Study: 10636351

Group type: EXPERIMENTAL
Intervention: Collagen deposition in men younger than 45 years
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Collagen deposition in men older than 45 years
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Collagen deposition in women younger than 45 years
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Collagen deposition in women older than 45 years
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Comparison of collagen deposition between men and women
Number of subjects: 116
Study: 15321259

Group type: EXPERIMENTAL
Intervention: Intravenous nalmefene 0.25 micro.kg(‐1) every 12 h x 2
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravenous nalmefene 0.5 microg.kg(‐1) every 12 h x 2
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Naloxone infusion 48 microg.h(‐1) (1.2 microg.ml(‐1))
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 80
Study: 1738553

Group type: EXPERIMENTAL
Intervention: Antibiotic eardrops administered to right ears intraoperatively and for 3 days post-surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: No antibiotic eardrops (control) administered to left ears
Number of subjects: 200
Study: 4006253

Group type: EXPERIMENTAL
Intervention: slow release Nifedipine (srN) 20 mg b.d.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: slow release Nifedipine (srN) 20 mg b.d. plus Acebutolol (A) 400 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: placebo (P)
Number of subjects: 11
Study: 30703062

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 29635145

Group type: EXPERIMENTAL
Intervention: Extended letrozole (2.5 or 5 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early treatment discontinuation
Number of subjects: 0
Study: 27508126

Group type: EXPERIMENTAL
Intervention: Septoplasty with partial inferior turbinectomy (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Septoplasty alone (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 60
Study: 25403215

Group type: EXPERIMENTAL
Intervention: Abstract with spin
Number of subjects: 300

Group type: COMPARATOR
Intervention: Abstract without spin
Number of subjects: 300
Study: 21745326

Group type: EXPERIMENTAL
Intervention: Early loading (1 week after surgery)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Delayed loading (3 months after surgery)
Number of subjects: 26
Study: 20205171

Group type: EXPERIMENTAL
Intervention: Suprathreshold gustatory stimuli
Number of subjects: 34
Study: 18812115

Group type: EXPERIMENTAL
Intervention: 0.1 mL preservative‐free lidocaine hydrochloride 1% injected in the capsular bag during hydrodissection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS) (control group)
Number of subjects: 120
Study: 15987916

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 12913083

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (PPC) with 5-FU (320 mg/m²/day for 5 days) and postoperative chemotherapy with MMC (6 mg/m²) and oral 5-FU (200 mg/day for 6 months)
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (PC) with MMC (6 mg/m²) and oral 5-FU (200 mg/day for 6 months)
Number of subjects: 1355

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (PPC)
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (PC)
Number of subjects: 1355
Study: 10337848

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention (C-B), 8 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Attention-only (A-O) placebo telephone calls, 8 weeks
Number of subjects: 65
Study: 7572702

Group type: EXPERIMENTAL
Intervention: Dietary calcium intake of 1768 mg/d (44 mmol/d)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Halving daily sodium excretion
Number of subjects: 124

Group type: COMPARATOR
Intervention: Urinary sodium excretion
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Dietary calcium intake and urine sodium excretion
Number of subjects: 124
Study: 1951503

Group type: EXPERIMENTAL
Intervention: 2.5 mg methylcellulose gel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 mg controlled-release pessary
Number of subjects: 40
Study: 6216050

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide
Number of subjects: 60
Study: 31261231

Group type: EXPERIMENTAL
Intervention: None (observational study)
Number of subjects: 88
Study: 28118733

Group type: EXPERIMENTAL
Intervention: Botulax (309.21±62.48U)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Botox (312.64±49.99U)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Both Botulax and Botox
Number of subjects: 187
Study: 25720622

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES) and Biolimus-eluting stents (BES)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: BVS
Number of subjects: 240

Group type: COMPARATOR
Intervention: EES/BES
Number of subjects: 240
Study: 24311014

Group type: COMPARATOR
Intervention: T2 MRI
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: T2 + DWI MRI
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: T2 + Gadolinium MRI
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: T2 + DWI MRI vs T2 + Gadolinium MRI
Number of subjects: 52
Study: 23151703

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid suture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Black silk suture
Number of subjects: 50
Study: 19684236

Group type: EXPERIMENTAL
Intervention: Strict glucose control with predominantly meal related insulin using subcutaneous insulin
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Strict glucose control with predominantly basal insulin using intravenous insulin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional glucose lowering therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Hyperglycaemic control group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Meal related insulin group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Basal insulin group
Number of subjects: 33
Study: 17454716

Group type: EXPERIMENTAL
Intervention: Naltrexone and nicotine patch
Number of subjects: 385
Study: 15631893

Group type: EXPERIMENTAL
Intervention: Motion extrapolation algorithm based on average velocity with adjustments for recent observations
Number of subjects: 126
Study: 12115173

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg)
Number of subjects: 632

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 632
Study: 10194050

Group type: EXPERIMENTAL
Intervention: Well-adjusted target
Number of subjects: 94

Group type: COMPARATOR
Intervention: Poorly adjusted target
Number of subjects: 94

Group type: COMPARATOR
Intervention: Unspecified psychological and physical health status
Number of subjects: 94
Study: 7583815

Group type: EXPERIMENTAL
Intervention: Women born in the late 1920s and early 1930s
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Women with traditional lifestyles
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Women with competing roles such as employment
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Subgroup analyses by cohort and educational level
Number of subjects: 293
Study: 2389686

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 65
Study: 7195723

Group type: EXPERIMENTAL
Intervention: Eupatorium perfoliatum D2
Number of subjects: 53

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 53
Study: 31937442

Group type: EXPERIMENTAL
Intervention: Kinesiotaping in addition to flurbiprofen 200 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flurbiprofen 200 mg/day (Control)
Number of subjects: 30
Study: 29644383

Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for vaginal hysterectomy (VH)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for anterior repair (AR)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for posterior repair (PR)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for vaginal hysterectomy (VH) for residents who had never performed VH
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for posterior repair (PR) for residents who had never performed PR
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for first and second year residents
Number of subjects: 46

Group type: COMPARATOR
Intervention: Self-directed learning (control)
Number of subjects: 46
Study: 27623523

Group type: EXPERIMENTAL
Intervention: Soft tissue techniques
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Neural mobilization techniques
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Combination of soft tissue and neural mobilization techniques
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo superficial massage
Number of subjects: 97
Study: 25826649

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) administration prior to exposure therapy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 23565674

Group type: EXPERIMENTAL
Intervention: Integration of chronic disease prevention and management (CDPM) services into primary health care
Number of subjects: 489
Study: 21852519

Group type: EXPERIMENTAL
Intervention: Bicycle intervention (5-day intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicycle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 19184209

Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 18
Study: 17426195

Group type: EXPERIMENTAL
Intervention: Methylprednisolone infusion (1 mg/kg/d)
Number of subjects: 91
Study: 15142301

Group type: EXPERIMENTAL
Intervention: Visual trials-to-criterion tasks with varying numbers of pre-exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory trials-to-criterion tasks with varying numbers of pre-exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual trials-to-criterion tasks with very low numbers of pre-exposure in high positive-schizotypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual trials-to-criterion tasks with very low numbers of pre-exposure in low positive-schizotypes
Number of subjects: 0
Study: 10871565

Group type: EXPERIMENTAL
Intervention: Very-low-energy or low-energy diet for 3 months followed by a weight-maintenance diet for up to 2 years
Number of subjects: 16
Study: 9380299

Group type: EXPERIMENTAL
Intervention: 2.5% natural vaginal progesterone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 1610632

Group type: EXPERIMENTAL
Intervention: i.v. fluid 1000 ml
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ephedrine 24 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: methoxamine 4 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: fluid preloading
Number of subjects: 45
Study: 6380281

Group type: EXPERIMENTAL
Intervention: Methadone (2.5 or 5 mg) + Ibuprofen (600 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Methadone alone
Number of subjects: 28
Study: 31101688

Group type: EXPERIMENTAL
Intervention: Neo‐adjuvant chemotherapy (three cycles of platinum/paclitaxel chemotherapy)
Number of subjects: 90
Study: 30140094

Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 0
Study: 26340471

Group type: EXPERIMENTAL
Intervention: Training mask at 9,000 ft (9K)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Training mask at 15,000 ft (15K)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham configuration (∼3,500 ft)
Number of subjects: 10
Study: 26511879

Group type: EXPERIMENTAL
Intervention: Retromuscular light-weight polypropylene mesh (Parietene Light™, Covidien)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional colostomy formation
Number of subjects: 150
Study: 23199430

Group type: EXPERIMENTAL
Intervention: MTBI group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 20051216

Group type: EXPERIMENTAL
Intervention: REFLECT statement for livestock and food safety
Number of subjects: 24

Group type: COMPARATOR
Intervention: CONSORT checklist
Number of subjects: 24
Study: 18663162

Group type: EXPERIMENTAL
Intervention: 20% low-fat dietary pattern with increased vegetables, fruits, and grains (n = 19,541)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Usual-diet comparison group (n = 29,294)
Number of subjects: 48835

Group type: EXPERIMENTAL
Intervention: 20% low-fat dietary pattern
Number of subjects: 48835
Study: 15582252

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25mg/day plus finasteride 5mg/day (group B)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Finasteride 5mg/day alone (group A)
Number of subjects: 46
Study: 12565779

Group type: EXPERIMENTAL
Intervention: 2% lignocaine hydrochloride gel (Instillagel)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plain aqueous gel
Number of subjects: 100
Study: 10646679

Group type: EXPERIMENTAL
Intervention: Ureterorenoscopy (URS)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Shockwave lithotripsy (SWL)
Number of subjects: 156
Study: 8739937

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation using self-reinforced polyglycolide (SR-PGA) screws, poly-l-lactide (SR-PLLA) screw, small (SR-PGA) rods, and Kirschner-wires.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conservative treatment followed by operation for removal of non-united fragment and reattachment of ligaments and muscles.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Primary excision of the fragment.
Number of subjects: 21